The CEO Statement Israeli's statement, reported by BMJ on May 19, 2026, marks one of the first on-record comments from a generic manufacturer chief executive following Health Canada's authorization of generic semaglutide
01dragonslayer 1Purpose Staff member Registered Joined May 13, 2016 Messages 16,127 Reaction score 10,814 Location Marvel Universe You want appetite control that actually holds when the cut gets ugly, you want fat off without flattening every pump, and you want a playbook that respects real life, not just clinical graphs
In addition, there is some evidence that patients started on GLP-1 RAs may actually decrease their physical activity 39
In some individuals with persistent, debilitating fatigue following SRAS-CoV-2 infection, documented damage of vital organs may be a sufficient explanation for their fatigue